Idiotype-specific suppression of MOPC-315 IgA secretion in vivo: reversible blockade of secretory myeloma cells by soluble mediators.
D000818:Animals; D001667:Binding, Competitive; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic; D004058:Diffusion; D006386:Hemagglutination Tests; D007070:Immunoglobulin A / Q000096:biosynthesis*; D007130:Immunoglobulin Idiotypes; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma / Q000276:immunology*; D011402:Pronase / Q000494:pharmacology; D012995:Solubility; D014301:Trinitrobenzenes / Q000276:immunology
D007070:Immunoglobulin A; D007130:Immunoglobulin Idiotypes; D014301:Trinitrobenzenes; D011402:Pronase